FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
$120.00
Lost, stolen, or damaged? We replace it, on us.
Pick your speed at checkout.
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), supplied by Peppy Peptides as a lyophilized peptide for laboratory research use only. Sermorelin remains a compound of interest in endocrine, neuroendocrine and peptide research.
Sermorelin is a synthetic peptide analogue of GHRH, the hypothalamic peptide that signals through the GHRH receptor. Because of this structural relationship, it has been studied in laboratory and preclinical research on GHRH receptor signaling and pituitary physiology.
Sermorelin is referenced in laboratory and preclinical research involving:
Laboratories working in endocrine, neuroendocrine and peptide research study it as a GHRH-analogue research compound.
Sermorelin is studied in laboratory and preclinical research involving GHRH receptor signaling, pituitary physiology and related endocrine pathways.
Sermorelin is supplied as a lyophilized (freeze-dried) research-grade peptide.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Price range: $125.00 through $175.00
Price range: $150.00 through $650.00
Price range: $125.00 through $700.00
$150.00
$175.00
Lab-verified quality
Each lot is analysed by Bioviridian before release. Below is the Certificate of Analysis for the most recent lot, as issued by the laboratory.
Overall purity
99.7%
RP-HPLC (214 nm)
View the signed COA (PDF)Check this certificate at bioviridians.com/coa-search.html with code COA7699.
Test results
5 of 5 conformHPLC retention time 10.354 min · Signed: Shane Straight, M.S., Principal Chemist, Bioviridian Inc.
Every lot keeps its own signed certificate. Lots are listed newest first.
Lot SERM072026-MG
99.7%
Overall purity
Tested July 13, 2026
Open COAEarlier lots will appear here as new Certificates of Analysis are published.
Compound details
Molecular profile
Storage requirements
Store lyophilized material at -20°C, protected from moisture and light; refer to batch-specific documentation for storage and stability information
Published literature
3 peer-reviewed publications indexed on PubMed. Listed for reference only; inclusion does not imply any use, effect or endorsement.
BIOCHEM BIOPHYS RES COMMUN · 1984
Ling N, Baird A, Wehrenberg WB, et al. Biochem Biophys Res Commun. 1984;123(2):854-61. doi:10.1016/0006-291x(84)90309-7
Synthesised C-terminally truncated analogues of human GRF, including GRF(1-29)NH2, and tested their bioactivity in cultured rat pituitary cells.
J MED CHEM · 1992
Gaudreau P, Boulanger L, Abribat T J Med Chem. 1992;35(10):1864-9. doi:10.1021/jm00088a023
Measured the binding affinity of hGRF(1-29)NH2 analogues for GRF binding sites in rat anterior pituitary membranes.
BRAIN RES · 1993
Boulanger L, Lazure C, Lefrançois L, et al. Brain Res. 1993;616(1-2):39-47. doi:10.1016/0006-8993(93)90189-t
Characterised the proteolytic degradation products of rat GRF(1-29)NH2 in rat pituitary and hypothalamic preparations.
